
Lenvatinib With or Without Immune Checkpoint Inhibitors in Subsets of Advanced Hepatocellular Carcinoma
Author(s) -
YuXian Teng
Publication year - 2022
Publication title -
eurasian journal of medicine and oncology
Language(s) - English
Resource type - Journals
eISSN - 2587-2400
pISSN - 2587-196X
DOI - 10.14744/ejmo.2022.25618
Subject(s) - lenvatinib , medicine , hepatocellular carcinoma , oncology , sorafenib , gastroenterology